ArticleFrontiers in oncology2022

Long-term clinical outcomes and prognostic factors of upfront surgery as a first-line therapy in biopsy-proven clinical N2 non-small cell lung cancer.

Luca Bertolaccini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.